Sai‐Yang Zhang
- Organic Chemistry top 2%
- Synthesis and biological activity 41
- Synthesis and Biological Evaluation 22
- Click Chemistry and Applications 18
- Synthesis and Characterization of Heterocyclic Compounds 8
- Toxicology top 2%
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways 14
- Histone Deacetylase Inhibitors Research 10
- Protein Degradation and Inhibitors 9
- Oncology top 10%
- Peptidase Inhibition and Analysis 11
- Cell Biology top 10%
- Co-authors
- Jian SongYanbing ZhangDong‐Jun FuHong‐Min LiuXiaolin ZiXin-Yi TianXiujuan LiuCheng‐Yun Jin
- Partner nations
- ChinaNew ZealandUnited States
In The Last Decade
Sai‐Yang Zhang
97 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Organic Chemistry 970
- Toxicology 80
- Molecular Biology 934
- Oncology 329
- Cell Biology 144
Countries citing papers authored by Sai‐Yang Zhang
This map shows the geographic impact of Sai‐Yang Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sai‐Yang Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sai‐Yang Zhang more than expected).
Fields of papers citing papers by Sai‐Yang Zhang
This network shows the impact of papers produced by Sai‐Yang Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sai‐Yang Zhang. The network helps show where Sai‐Yang Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sai‐Yang Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 4 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 15 | |
| 9 | 2024 | 19 | |
| 10 | 2024 | 5 | |
| 11 | 2024 | 4 | |
| 12 | 2024 | 1 | |
| 13 | Recent development of multi-target VEGFR-2 inhibitors for the cancer therapybreakdown → | 2023 | 93 |
| 14 | 2023 | 12 | |
| 15 | 2023 | 11 | |
| 16 | 2023 | 9 | |
| 17 | 2022 | 34 | |
| 18 | 2021 | 0 | |
| 19 | 2021 | 18 | |
| 20 | 2020 | 7 |
About Sai‐Yang Zhang
Sai‐Yang Zhang is a scholar working on Organic Chemistry, Oncology and Molecular Biology, having authored 103 papers that have together received 1.9k indexed citations. Recurring topics across this work include Synthesis and biological activity (41 papers), Synthesis and Biological Evaluation (22 papers), Click Chemistry and Applications (18 papers), Ubiquitin and proteasome pathways (14 papers), Peptidase Inhibition and Analysis (11 papers), Histone Deacetylase Inhibitors Research (10 papers), Protein Degradation and Inhibitors (9 papers) and Synthesis and Characterization of Heterocyclic Compounds (8 papers). The work is most often cited by research in Organic Chemistry (970 citations), Toxicology (80 citations) and Molecular Biology (934 citations). Sai‐Yang Zhang has collaborated with scholars based in China, New Zealand and United States. Frequent co-authors include Jian Song, Yanbing Zhang, Dong‐Jun Fu, Hong‐Min Liu, Xiaolin Zi, Xin-Yi Tian, Xiujuan Liu, Cheng‐Yun Jin, Christopher Blair and Shuo Yuan. Their work appears in journals such as Nature Communications, Scientific Reports and Carbohydrate Polymers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.